Blood cell mutations and inflammation registry
Treatments studied
Part of Blood & lymphatic clinical trials.
This study collects blood samples and health information from people with certain unexplained blood cell changes or those at higher risk for them, to learn how these changes relate to inflammation and heart health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have unexplained low or high blood counts, or certain blood cell mutations (like CHIP or CCUS)
- Or you have a history of solid tumors or heart disease, which can increase risk for these blood changes
- You do not have an active blood cancer (like leukemia or MDS), but past blood cancers in remission are okay
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how certain age-related changes in blood cells (called clonal hematopoiesis) affect inflammation and health. It aims to understand why some people with these changes develop health problems like heart disease or blood disorders, while others stay healthy. Depending on your situation, you might join a group that has these changes but no health issues, or a group that has them along with specific conditions.
This study looks at a condition called clonal hematopoiesis (CH), where some blood cells have changes that may affect their health. It aims to prevent, treat, and better understand CH. You may qualify if you are 55 or older and have low blood counts that persist over time.
This study tests whether eating more plant-based whole foods can help people with clonal hematopoiesis (a condition where blood cells grow from a single mutated cell). Researchers want to understand if dietary changes affect this condition and collect health information over time.
This study follows people who may have early, unclear blood count problems or certain genetic/immune patterns that can later lead to bone marrow failure or blood cancers. It may help doctors better understand risks over time and guide earlier care.
This study looks at blood cell changes that can affect the immune system. It aims to better understand how these changes relate to immune problems and related diseases, and what might matter for treatment decisions.
This study follows adults who have certain blood-cell DNA changes (CHIP or CCUS) to learn how their condition may progress over time. It mainly looks at natural history—what happens in the blood without giving an active treatment.
Hear when a new Clonal Hematopoiesis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.